STAT Plus: A pariah in science, the ‘CRISPR babies’ researcher gains support from a U.S. cryptocurrency entrepreneur
biotechnolgy
Latest
STAT Plus: Moderna reports encouraging results on its mpox vaccine, as outbreaks in Africa spread
STAT Plus: Eli Lilly’s billions: Can the world’s most valuable pharma company keep inventing drugs at this pace?
STAT Plus: For national security, the U.S. must maintain its biotech dominance
STAT Plus: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership
STAT Plus: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution
STAT Plus: David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells
STAT Plus: Gene therapy is in crisis. For nine hours, the field’s leading minds looked for a solution